Starling Oncology, Inc. (DFPH) Total liabilities 2020–2025
Starling Oncology, Inc. (DFPH) total liabilities at each fiscal year-end, per SEC filings.
$180.4MFY2025 · since FY2020: $37.6M → $180.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $180.4M | +6.7% |
| FY2024 | $169.1M | +11.1% |
| FY2023 | $152.2M | +9.9% |
| FY2022 | $138.5M | +39.5% |
| FY2021 | $99.3M | +164.1% |
| FY2020 | $37.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Operating cash flowDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total assetsDFPH Shareholders’ equityDFPH overview →